A detailed history of Aqr Capital Management LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 58,091 shares of TECH stock, worth $4.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
58,091
Previous 50,230 15.65%
Holding current value
$4.24 Million
Previous $3.6 Million 29.02%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.96 - $82.35 $557,816 - $647,353
7,861 Added 15.65%
58,091 $4.64 Million
Q2 2024

Aug 14, 2024

SELL
$62.12 - $84.15 $53,361 - $72,284
-859 Reduced 1.68%
50,230 $3.6 Million
Q1 2024

May 15, 2024

SELL
$65.98 - $77.09 $611,766 - $714,778
-9,272 Reduced 15.36%
51,089 $3.6 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $990,351 - $1.47 Million
18,746 Added 45.05%
60,361 $4.66 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $364,067 - $482,152
5,392 Added 14.89%
41,615 $2.83 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $3.42 Million - $3.99 Million
-46,404 Reduced 56.16%
36,223 $2.96 Million
Q1 2023

May 15, 2023

SELL
$71.62 - $86.62 $5.88 Million - $7.12 Million
-82,154 Reduced 49.86%
82,627 $6.13 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $10.4 Million - $45.2 Million
128,325 Added 352.0%
164,781 $13.7 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $1.15 Million - $1.59 Million
-4,066 Reduced 10.03%
36,456 $10.4 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $748,594 - $1.04 Million
-2,320 Reduced 5.42%
40,522 $13.8 Million
Q1 2022

May 16, 2022

SELL
$353.85 - $487.79 $6.24 Million - $8.6 Million
-17,623 Reduced 29.15%
42,842 $18.6 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $6.82 Million - $7.84 Million
14,941 Added 32.82%
60,465 $30.8 Million
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $4.91 Million - $5.95 Million
11,042 Added 32.02%
45,524 $22.1 Million
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $4 Million - $4.65 Million
-10,322 Reduced 23.04%
34,482 $15.4 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $3.63 Million - $4.75 Million
-11,548 Reduced 20.49%
44,804 $17.1 Million
Q4 2020

Feb 16, 2021

SELL
$246.9 - $321.87 $37,281 - $48,602
-151 Reduced 0.27%
56,352 $17.9 Million
Q3 2020

Nov 16, 2020

SELL
$232.22 - $282.96 $1.86 Million - $2.27 Million
-8,017 Reduced 12.43%
56,503 $14 Million
Q2 2020

Aug 17, 2020

SELL
$185.43 - $279.56 $6.14 Million - $9.26 Million
-33,131 Reduced 33.93%
64,520 $16.5 Million
Q1 2020

May 15, 2020

BUY
$161.17 - $221.51 $3.23 Million - $4.44 Million
20,043 Added 25.83%
97,651 $18.5 Million
Q4 2019

Feb 14, 2020

SELL
$189.68 - $222.09 $8.77 Million - $10.3 Million
-46,243 Reduced 37.34%
77,608 $16.9 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $13.3 Million - $15.7 Million
-72,291 Reduced 36.86%
123,851 $24.2 Million
Q2 2019

Aug 14, 2019

SELL
$188.72 - $215.43 $1.2 Million - $1.37 Million
-6,345 Reduced 3.13%
196,142 $40.6 Million
Q1 2019

May 14, 2019

SELL
$136.09 - $200.44 $23.2 Million - $34.1 Million
-170,333 Reduced 45.69%
202,487 $40.1 Million
Q4 2018

Feb 14, 2019

BUY
$132.75 - $203.8 $19.4 Million - $29.8 Million
146,411 Added 64.67%
372,820 $54 Million
Q3 2018

Nov 15, 2018

BUY
$147.44 - $204.11 $16.7 Million - $23.1 Million
112,946 Added 99.54%
226,409 $46.2 Million
Q2 2018

Aug 14, 2018

BUY
$144.9 - $165.58 $8.53 Million - $9.74 Million
58,848 Added 107.75%
113,463 $16.8 Million
Q1 2018

May 15, 2018

BUY
$131.46 - $151.04 $6.02 Million - $6.91 Million
45,779 Added 518.1%
54,615 $8.25 Million
Q4 2017

Feb 14, 2018

BUY
$121.17 - $134.75 $302,803 - $336,740
2,499 Added 39.44%
8,836 $1.14 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $719,819 - $784,393
6,337
6,337 $766,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.